Evidence map›Paper›PMID 40414661›Full record

SynthesisInterventional cardiology clinics2025

Late Outcomes After Transcatheter Aortic Valve Implantation with Balloon-Versus Self-Expandable Valves: Meta-Analysis of Reconstructed Time-To-Event Data.

Xander Jacquemyn, Jef Van den Eynde, Tulio Caldonazo, James A Brown, Aleksander Dokollari, Derek Serna-Gallegos, Marie-Annick Clavel, Philippe Pibarot, Ibrahim Sultan, Michel Pompeu Sá

Abstract readMeta-AnalysisReview
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Interventional cardiology clinics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xander JacquemynDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Jef Van den EyndeDepartment of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.
Tulio CaldonazoDepartment of Cardiothoracic Surgery, Friedrich Schiller University, Jena, Germany.
James A BrownDepartment of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA; UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Aleksander DokollariDepartment of Cardiac Surgery, St. Boniface Hospital, University of Manitoba, Winnepeg, Canada.
Derek Serna-GallegosDepartment of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA; UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Marie-Annick ClavelCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec City, Québec, Canada; Department of Medicine, Université Laval, Québec City, Québec, Canada.
Philippe PibarotCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec City, Québec, Canada; Department of Medicine, Université Laval, Québec City, Québec, Canada.
Ibrahim SultanDepartment of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA; UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Michel Pompeu SáDepartment of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA; UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Electronic address: michel_pompeu@yahoo.com.br.

Funding

Cardiothoracic Surgery Research Training ProgramT32HL160526 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JAMES D LUKETICH, Julie A Phillippi · 2022 to 2026
$1.5M
NHLBI NIH HHS T32 HL160526
6 · The paper itself

Abstract

Self-expanding valves (SEV) and balloon-expandable valves (BEV) for transcatheter aortic valve implantation (TAVI) have their own features. There is a growing interest in long-term outcomes with the adoption of lifetime management in younger patients. To evaluate late outcomes in TAVI with SEV versus BEV, we performed a study-level meta-analysis of reconstructed time-to-event data published by May 31, 2023. We found no statistically significant difference in all-cause death after TAVI with SEV versus BEV. Randomized controlled trials are warranted to validate our results.

Indexed as

Aortic ValveAortic Valve StenosisHeart Valve ProsthesisTranscatheter Aortic Valve ReplacementHumansProsthesis DesignTime FactorsTreatment OutcomeAortic valveCardiac surgical proceduresCardiovascular surgical proceduresHeart valve prosthesis implantationMeta-analysisTranscatheter aortic valve replacement

Identifiers

PMID40414661
PMCPMC12283095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.